NCT00315185View on ClinicalTrials.gov

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2008

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Cetuximab

Trial Locations (1)

19026

Consultants in Medical Oncology & Hematology Inc., Drexel Hill

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER

NCT00315185 - Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | Biotech Hunter | Biotech Hunter